Induction of indoleamine-2,3 dioxygenase in bone marrow stromal cells inhibits myeloma cell growth

Tumor-Educated Tolerogenic Dendritic Cells Induce CD3  Down-Regulation and Apoptosis of T Cells through Oxygen-Dependent Pathways

(2014) D.-M. Kuang et al.   JOURNAL OF IMMUNOLOGY

Upregulated expression of indoleamine 2, 3-dioxygenase in CHO cells induces apoptosis of competent T cells and increases proportion of Treg cells

(2011) Jingyan Sun et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells

(2011) Maria T Pallotta et al.   NATURE IMMUNOLOGY

Interferon- -triggered indoleamine 2,3-dioxygenase competence in human monocyte-derived dendritic cells induces regulatory activity in allogeneic T cells

(2009) B. Jurgens et al.   BLOOD

Functional Alteration of the Lymphoma Stromal Cell Niche by the Cytokine Context: Role of Indoleamine-2,3 Dioxygenase

(2009) H. Maby-El Hajjami et al.   CANCER RESEARCH

Immune Suppression by γδ T-cells as a Potential Regulatory Mechanism After Cancer Vaccination With IL-12 Secreting Dendritic Cells

(2009) Michael W. Traxlmayr et al.   JOURNAL OF IMMUNOTHERAPY

Inverse Correlation between Tumoral Indoleamine 2,3-Dioxygenase Expression and Tumor-Infiltrating Lymphocytes in Endometrial Cancer: Its Association with Disease Progression and Survival

(2008) K. Ino et al.   CLINICAL CANCER RESEARCH

High INDO (indoleamine 2,3-dioxygenase) mRNA level in blasts of acute myeloid leukemic patients predicts poor clinical outcome

(2008) M. E.D. Chamuleau et al.   HAEMATOLOGICA